Royalty Report: Drugs, Cannabis, Cancer – Collection: 264659

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Drugs
  • Cannabis
  • Cancer
  • Disease
  • Pain
  • Arthritis
  • Therapeutic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 264659

License Grant
Licensee, a shareholder,  has a non-exclusive right to sell Prana Hemp in certain situations where the sale is to be completed through the use of a credit card associated with a merchant account owned and/or controlled by Licensee.
License Property
The intellectual property we licensed includes know-how relating to the design and buildout of cultivation facilities, growing/cultivation systems, seed-to-sale protocols and procedures, products, access to a genetic catalogue including over 150 different strains, an advanced (non-psychoactive) cannabinoid sequencing therapy program utilizing patent-pending Prana Bio Nutrient Medicinals called the A.C.T. Now Program (“ACT Now” or “ACT Now Program”), security, regulatory compliance, and other methods and processes which relate to the cannabis industry.

Licensor is a biotech company focused on developing targeted therapeutics for the prevention of the negative side effects of chemotherapy, management of rheumatoid arthritis and treatment of brain cancer. The focus is on extracting products from industrial hemp plants, which the Licensor wholesale to manufacturers, and which are used to create unique therapeutics for a wide range of diseases that can be utilized by patients globally. Licensor own distinct intellectual property relating to the legalized growth, production, manufacture, marketing, management, utilization and distribution of medical and recreational marijuana and marijuana infused products.

Field of Use
This agreement pertains to the drug industry.  The intellectual property is licensed to businesses in the cannabis industry.

IPSCIO Record ID: 244979

License Grant
Licensor hereby grants to Licensee an exclusive, non-transferable, non-sublicenseable license in one or more cities in California (the “Territory”) to manufacture and distribute Licensor's Prana formulation products set forth on “Licensed Products”.

Licensor hereby grants to Licensee the exclusive, non-transferable, non-sublicenseable right and license to use the trademarks, service marks, trade names, trade dress, symbols and logos set forth.

License Property
Licensor owns and holds certain intellectual property related to its proprietary Prana formulation, cannabis manufacturing, delivery methods and software and provides consulting services to cannabis related businesses and access to its professional network (the “Intellectual Property” and “Consulting Services”).

Prana products focus on targeted therapeutics for prevention of the negative side effects of chemotherapy, management of rheumatoid arthritis and treatment of brain cancer.

The Intellectual Property consists of the following, along with all related Licensed Know-How:
1. Standard Operating Procedures
? Testing
? Packaging
? Employee Operating Procedures

2. Equipment Selection

3. Training
? On-site training at ADVESA’s facility
? On-site training at UCAN’s facility

Prana “Bio Nutrient Medicinals” Capsule in the following varieties:
a. Prana P1;
b. Prana P2;
c. Prana P3; and
d. Prana P4;
e. Prana P5;
f.  All white label products in this category
2. Prana “Bio Nutrient Medicinals” Sublingual in the following varieties:
a. Prana P1;
b. Prana P2;
c. Prana P3; and
d. Prana P4.
e. Prana P5;
f. All white label products in this category
3. Prana “Bio Nutrient Medicinals” Topicals in the following varieties:
a. Prana P1;
b. Prana P2;
c. Prana P3; and
d. Prana P4.
e. Prana P5
f. All white label products in this category

Field of Use
Licensee is engaged in the business of processing, extracting and providing of legal medical cannabis and cannabis products pursuant to the laws and regulations of the State of California and the rules and regulations of relevant local jurisdictions.

IPSCIO Record ID: 239294

License Grant
In this agreement the Licensee is to produce cannabis-infused baked goods and other edibles in Licensor’s production facility upon approval of Licensor’s Nevada Medical Marijuana Production License.
License Property
The Company (Licensor) seeks to be an innovative technology and solution company that converts the cannabis plant into medicines, therapies and treatments for a variety of ailments. The Company is developing and utilizing state of the art technologies in plant biology, cultivation and extraction techniques, combined with biotechnology, and plans to produce consistent and measurable medical-grade cannabis, cannabis concentrates and cannabinoid therapies.
Field of Use
This agreement pertains to the drug industry relating to cannabis-based therapeutic products.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.